查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1356792

排卵症诊断市场报告：2030 年趋势、预测与竞争分析

Ovulation Disorder Diagnosis Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

排卵障碍诊断的趋势和预测

到 2030 年，全球排卵症诊断市场预计将达到 8 亿美元，2024 年至 2030 年年复合成长率为 6.1%。这个市场的主要促进因素是越来越多地采用计划怀孕、人们对各种排卵障碍的认识不断提高以及出生率下降。全球排卵障碍诊断市场的未来前景广阔，医院、妇科诊所和诊断中心市场充满机会。

排卵障碍诊断市场洞察

Lucintel 预测，由于第 2 型糖尿病患者 PCOD 发病率不断增加，多囊性卵巢症候群预计在预测期内增长最快。

医院仍然是该市场中最大的部分。

由于先进的医疗基础设施和公众对排卵障碍诊断意识的提高，预计北美在预测期内将出现最高的增长。

本报告回答了 11 个关键问题：

  • Q.1. 细分市场中最有前途和高成长的机会是什么？
  • Q.2. 未来哪个细分市场成长较快？为什么？
  • Q.3.您认为哪些地区未来会出现更快的成长？为什么？
  • Q.4. 影响市场动态的主要要素有哪些？市场的主要挑战和商业风险是什么？
  • Q.5. 这个市场的商业风险和竞争威胁是什么？
  • Q.6.这个市场有哪些新趋势？为什么？
  • Q.7.市场客户需求有何改变？
  • Q.8. 该市场有哪些新发展以及哪些公司处于领先地位？
  • Q.9.这个市场的主要企业有哪些？主要企业采取哪些策略配合措施来发展业务？
  • Q.10. 该市场上的竞争产品有哪些，由于材料或产品替代导致市场占有率下降的威胁有多大？
  • Q.11.过去年度发生了哪些併购事件，对产业产生了哪些影响？

目录

第1章执行摘要

第2章全球排卵症诊断市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业促进因素与挑战

第3章2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球排卵症诊断市场趋势（2018-2023）与预测（2024-2030）
  • 按排卵障碍分類的全球排卵障碍诊断市场
    • 多囊性卵巢症候群
    • 高催乳素血症
    • 黄体期不足
    • 下视丘功能障碍
    • 瘤
    • 自体免疫卵巢炎
    • 原发性卵巢功能衰竭
    • 抵抗性卵巢症候群
    • 其他的
  • 全球排卵症诊断市场（按诊断）
    • 荷尔蒙实验室测试
    • 脑下垂体和下视丘的 CT 和 MRI 扫描
    • 卵巢切片检查
    • 其他的
  • 全球排卵障碍诊断市场（按最终用途）
    • 医院
    • 妇科门诊
    • 诊断中心
    • 其他的

第4章2018-2030年分地区市场趋势及预测分析

  • 按地区分類的全球排卵障碍诊断市场
  • 北美排卵障碍诊断市场
  • 欧洲排卵症诊断市场
  • 亚太排卵症诊断市场
  • 其他区域排卵障碍诊断市场

第5章竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第6章成长机会与策略分析

  • 成长机会分析
    • 排卵障碍在全球排卵障碍诊断市场的成长机会
    • 全球排卵症诊断市场诊断成长机会
    • 全球排卵障碍诊断市场的成长机会（以最终用途）
    • 按地区分類的全球排卵障碍诊断市场成长机会
  • 全球排卵症诊断市场新趋势
  • 战略分析
    • 新产品开发
    • 扩大全球排卵障碍诊断市场的产能
    • 全球排卵障碍诊断市场的合併、收购和合资企业
    • 认证和许可

第7章主要企业概况

  • Siemens Healthcare
  • GE Healthcare
  • Fujifilm Holdings
  • Swiss Precision Diagnostics
  • Toshiba Medical Systems
  • Carestream Health
  • Genova Diagnostics
  • Quest Diagnostics
  • LabCorp
  • Esaote
简介目录

Ovulation Disorder Diagnosis Trends and Forecast

The future of the global ovulation disorder diagnosis market looks promising with opportunities in the hospital, gynecological clinic, and diagnostic center markets. The global ovulation disorder diagnosis market is expected to reach an estimated $0.8 billion by 2030 with a CAGR of 6.1% from 2024 to 2030. The major drivers for this market are increasing adoption of planned pregnancies, growing awareness towards different ovulation disorders, and decrease in fertility rate.

A more than 150-page report is developed to help in your business decisions.

Ovulation Disorder Diagnosis by Segment

The study includes a forecast for the global ovulation disorder diagnosis by ovulation disorders, diagnosis, end use, and region.

Ovulation Disorder Diagnosis Market by Ovulation Disorders [Shipment Analysis by Value from 2018 to 2030]:

  • Polycystic Ovarian Syndrome
  • Hyperprolactinemia
  • Luteal Phase Defect
  • Hypothalamus Dysfunction
  • Tumors
  • Autoimmune Oophoritis
  • Primary Ovarian Failure
  • Resistant Ovary Syndrome
  • Others

Ovulation Disorder Diagnosis Market by Diagnosis [Shipment Analysis by Value from 2018 to 2030]:

  • Laboratory Testing of Hormones
  • CT Scan and MRI Scan of The Pituitary Gland and Hypothalamus
  • Ovarian Biopsy
  • Others

Ovulation Disorder Diagnosis Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals
  • Gynecological Clinics
  • Diagnostic Centers
  • Others

Ovulation Disorder Diagnosis Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Ovulation Disorder Diagnosis Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies ovulation disorder diagnosis companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the ovulation disorder diagnosis companies profiled in this report include-

  • Siemens Healthcare
  • GE Healthcare
  • Fujifilm Holdings
  • Swiss Precision Diagnostics
  • Toshiba Medical Systems
  • Carestream Health
  • Genova Diagnostics
  • Quest Diagnostics
  • Labcorp
  • Esaote

Ovulation Disorder Diagnosis Market Insights

Lucintel forecasts that polycystic ovarian syndrome is expected to witness highest growth over the forecast period due to increasing incidence of PCOD in patients with type 2 diabetes.

Within this market, hospitals will remain the largest segment .

North America is expected to witness highest growth over the forecast period due to presence of advanced healthcare infrastructure and growing awareness in public towards ovulation disorder diagnosis.

Features of the Global Ovulation Disorder Diagnosis Market

Market Size Estimates: Ovulation disorder diagnosis market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Ovulation disorder diagnosis market size by ovulation disorders, diagnosis, end use, and region. in terms of value ($B).

Regional Analysis: Ovulation disorder diagnosis market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different ovulation disorders, diagnosis, end uses, and region.s for the ovulation disorder diagnosis market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the ovulation disorder diagnosis market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1. What is the ovulation disorder diagnosis market size?

Answer: The global ovulation disorder diagnosis market is expected to reach an estimated $0.8 billion by 2030.

Q.2. What is the growth forecast for ovulation disorder diagnosis market?

Answer: The global ovulation disorder diagnosis market is expected to grow with a CAGR of 6.1% from 2024 to 2030.

Q.3. What are the major drivers influencing the growth of the ovulation disorder diagnosis market?

Answer: The major drivers for this market are increasing adoption of planned pregnancies, growing awareness towards different ovulation disorders, and decrease in fertility rate.

Q.4. What are the major segments for ovulation disorder diagnosis market?

Answer: The future of the global ovulation disorder diagnosis market looks promising with opportunities in the hospital, gynecological clinic, and diagnostic center markets.

Q.5. Who are the key ovulation disorder diagnosis market companies?

Answer: Some of the key ovulation disorder diagnosis companies are as follows:

  • Siemens Healthcare
  • GE Healthcare
  • Fujifilm Holdings
  • Swiss Precision Diagnostics
  • Toshiba Medical Systems
  • Carestream Health
  • Genova Diagnostics
  • Quest Diagnostics
  • LabCorp
  • Esaote

Q.6. Which ovulation disorder diagnosis market segment will be the largest in future?

Answer: Lucintel forecasts that polycystic ovarian syndrome is expected to witness highest growth over the forecast period due to increasing incidence of PCOD in patients with type 2 diabetes.

Q.7. In ovulation disorder diagnosis market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to presence of advanced healthcare infrastructure and growing awareness in public towards ovulation disorder diagnosis.

Q.8. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the ovulation disorder diagnosis market by ovulation disorders (polycystic ovarian syndrome, hyperprolactinemia, luteal phase defect, hypothalamus dysfunction, tumors, autoimmune oophoritis, primary ovarian failure, resistant ovary syndrome, and others), diagnosis (laboratory testing of hormones, CT scan & MRI scan of the pituitary gland & hypothalamus, ovarian biopsy, and others), end use (hospitals, gynecological clinics, diagnostic centers, and others), and region. (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Ovulation Disorder Diagnosis Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Ovulation Disorder Diagnosis Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Ovulation Disorder Diagnosis Market by Ovulation Disorders
    • 3.3.1: Polycystic Ovarian Syndrome
    • 3.3.2: Hyperprolactinemia
    • 3.3.3: Luteal Phase Defect
    • 3.3.4: Hypothalamus Dysfunction
    • 3.3.5: Tumors
    • 3.3.6: Autoimmune Oophoritis
    • 3.3.7: Primary Ovarian Failure
    • 3.3.8: Resistant Ovary Syndrome
    • 3.3.9: Others
  • 3.4: Global Ovulation Disorder Diagnosis Market by Diagnosis
    • 3.4.1: Laboratory Testing of Hormones
    • 3.4.2: CT Scan and MRI Scan of The Pituitary Gland and Hypothalamus
    • 3.4.3: Ovarian Biopsy
    • 3.4.4: Others
  • 3.5: Global Ovulation Disorder Diagnosis Market by End Use
    • 3.5.1: Hospitals
    • 3.5.2: Gynecological Clinics
    • 3.5.3: Diagnostic Centers
    • 3.5.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Ovulation Disorder Diagnosis Market by Region
  • 4.2: North American Ovulation Disorder Diagnosis Market
    • 4.2.2: North American Ovulation Disorder Diagnosis Market by End Use: Hospitals, Gynecological Clinics, Diagnostic Centers, and Others
  • 4.3: European Ovulation Disorder Diagnosis Market
    • 4.3.1: European Ovulation Disorder Diagnosis Market by Ovulation Disorders: Polycystic Ovarian Syndrome, Hyperprolactinemia, Luteal Phase Defect, Hypothalamus Dysfunction, Tumors, Autoimmune Oophoritis, Primary Ovarian Failure, Resistant Ovary Syndrome, and Others
    • 4.3.2: European Ovulation Disorder Diagnosis Market by End Use: Hospitals, Gynecological Clinics, Diagnostic Centers, and Others
  • 4.4: APAC Ovulation Disorder Diagnosis Market
    • 4.4.1: APAC Ovulation Disorder Diagnosis Market by Ovulation Disorders: Polycystic Ovarian Syndrome, Hyperprolactinemia, Luteal Phase Defect, Hypothalamus Dysfunction, Tumors, Autoimmune Oophoritis, Primary Ovarian Failure, Resistant Ovary Syndrome, and Others
    • 4.4.2: APAC Ovulation Disorder Diagnosis Market by End Use: Hospitals, Gynecological Clinics, Diagnostic Centers, and Others
  • 4.5: ROW Ovulation Disorder Diagnosis Market
    • 4.5.1: ROW Ovulation Disorder Diagnosis Market by Ovulation Disorders: Polycystic Ovarian Syndrome, Hyperprolactinemia, Luteal Phase Defect, Hypothalamus Dysfunction, Tumors, Autoimmune Oophoritis, Primary Ovarian Failure, Resistant Ovary Syndrome, and Others
    • 4.5.2: ROW Ovulation Disorder Diagnosis Market by End Use: Hospitals, Gynecological Clinics, Diagnostic Centers, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Ovulation Disorder Diagnosis Market by Ovulation Disorders
    • 6.1.2: Growth Opportunities for the Global Ovulation Disorder Diagnosis Market by Diagnosis
    • 6.1.3: Growth Opportunities for the Global Ovulation Disorder Diagnosis Market by End Use
    • 6.1.4: Growth Opportunities for the Global Ovulation Disorder Diagnosis Market by Region
  • 6.2: Emerging Trends in the Global Ovulation Disorder Diagnosis Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Ovulation Disorder Diagnosis Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Ovulation Disorder Diagnosis Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Siemens Healthcare
  • 7.2: GE Healthcare
  • 7.3: Fujifilm Holdings
  • 7.4: Swiss Precision Diagnostics
  • 7.5: Toshiba Medical Systems
  • 7.6: Carestream Health
  • 7.7: Genova Diagnostics
  • 7.8: Quest Diagnostics
  • 7.9: LabCorp
  • 7.10: Esaote